splitomicin,
splitomicin,
5690-03-9,
1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one,
1,2-dihydro-3h-benzo[f]chromen-3-one,
1H-benzo[f]chromen-3(2H)-one,
CHEMBL86537,
CHEBI:75272,
1,2-dihydrobenzo[f]chromen-3-one,
MFCD08705254,
1H,2H,3H-naphtho[2,1-b]pyran-3-one,
Splitomycin,
Bio2_000878,
Tocris-1542,
AC1L1JZ6,
AC1Q6ML4,
BSPBio_001116,
KBioGR_000456,
KBioSS_000456,
GTPL8101,
SCHEMBL2544804,
BDBM29590,
KBio2_000456,
KBio2_003024,
KBio2_005592,
KBio3_000851,
KBio3_000852,
ZINC27374,
ISFPDBUKMJDAJH-UHFFFAOYSA-N,
Bio2_000398,
HMS1362H17,
HMS1792H17,
HMS1990H17,
HMS3268C11,
HMS3403H17,
HMS3676J05,
BCP10432,
2049AH,
2726AH,
GK9181,
s7593,
AKOS006288326,
CCG-208679,
Splitomicin, >=98% (HPLC), powder,
IDI1_002153,
NCGC00025208-01,
NCGC00025208-02,
NCGC00025208-03,
AJ-08463,
S0892,
EC-000.2450,
1,2-dihydro-3H-naphtho[2,1-b]-pyran-3-one,
A14221,
3H-Naphtho[2,1-b]pyran-3-one, 1,2-dihydro-,
SR-01000597607,
SR-01000597607-1,
BRD-K27710560-001-02-6,
I14-11730,
1-Naphthalenepropionic acid, 2-hydroxy-, .delta.-lactone,
D09SUO,
1-Naphthalenepropanoic acid,
CID5269,
KST-1A9411,
C13H10O2,
AR-1B5792,
A8242,
C444426,
5959-01-3,
Isobutylmagnesium chloride, 2M solution in diethyl ether, AcroSeal(R),
4707-36-2,